CLINICAL_TRIALS
trial_result
· 2017-08-02
Clinical Trial Update: Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome [Phase 2, Phase 3]
Summary
Clinical trial update on fecal microbiota transplantation for irritable bowel syndrome, covering Phase 2 and Phase 3 with the study status completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aleris-Hamlet Hospitaler København | Conditions: Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: COMPLETED